Macrophage Delivery of an Oncolytic Virus Abolishes Tumor Regrowth and Metastasis after Chemotherapy or Irradiation
- 15 January 2013
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 73 (2), 490-495
- https://doi.org/10.1158/0008-5472.can-12-3056
Abstract
Frontline anticancer therapies such as chemotherapy and irradiation often slow tumor growth, but tumor regrowth and spread to distant sites usually occurs after the conclusion of treatment. We recently showed that macrophages could be used to deliver large quantities of a hypoxia-regulated, prostate-specific oncolytic virus (OV) to prostate tumors. In the current study, we show that administration of such OV-armed macrophages 48 hours after chemotherapy (docetaxel) or tumor irradiation abolished the posttreatment regrowth of primary prostate tumors in mice and their spread to the lungs for up to 27 or 40 days, respectively. It also significantly increased the lifespan of tumor-bearing mice compared with those given docetaxel or irradiation alone. These new findings suggest that such a novel, macrophage-based virotherapy could be used to markedly increase the efficacy of chemotherapy and irradiation in patients with prostate cancer. Cancer Res; 73(2); 490–5. ©2012 AACR.Other Versions
This publication has 12 references indexed in Scilit:
- Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancerGenes & Development, 2011
- Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to ChemotherapyCancer Discovery, 2011
- Use of Macrophages to Target Therapeutic Adenovirus to Human Prostate TumorsCancer Research, 2011
- Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in miceJCI Insight, 2010
- Radiotherapy Decreases Vascular Density and Causes Hypoxia with Macrophage Aggregation in TRAMP-C1 Prostate TumorsClinical Cancer Research, 2009
- Increased therapeutic efficacy of the prostate-specific oncolytic adenovirus Ad[I/PPT-E1A] by reduction of the insulator size and introduction of the full-length E3 regionCancer Gene Therapy, 2008
- Radiation-Enhanced Vascular Targeting of Human Lung Cancers in Mice with a Monoclonal Antibody That Binds Anionic PhospholipidsClinical Cancer Research, 2007
- Hypoxia-Induced Gene Expression in Human Macrophages: Implications for Ischemic Tissues and Hypoxia-Regulated Gene TherapyThe American Journal of Pathology, 2003
- Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breastBritish Journal of Cancer, 1999
- Validation of the fluorescent dye Hoechst 33342 as a vascular space marker in tumoursBritish Journal of Cancer, 1988